COMARCH S.A. ZY 1/ PLCOMAR00012 /
30/05/2024 8:24:06 | Diferencia 0.00 | Volumen | Bid7:40:33 | Ask7:40:33 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
59.20EUR | 0.00% | 0 Volumen de negocios: 0.00 |
58.40Volumen de oferta: 100 | 61.20Tamaño/ Volumen/ Formato de Ask: 100 | 477.46 millonesEUR | - | - |
GlobeNewswire
8:00
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire
7:30
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
7:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
7:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
7:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
7:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
7:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
6:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
5:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página